Integral Derivatives’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$921K Buy
+5,401
New +$991K 0.02% 257
2017
Q1
Sell
-5,327
Closed -$885K 1143
2016
Q4
$779K Sell
5,327
-15,317
-74% -$2.31M 0.01% 582
2016
Q3
$3.44M Buy
20,644
+13,744
+199% +$2.32M 0.07% 163
2016
Q2
$1.05M Buy
+6,900
New +$1.07M 0.03% 403
2015
Q4
Sell
-5,014
Closed -$788K 1061
2015
Q3
$694K Sell
5,014
-6,884
-58% -$1.09M 0.02% 620
2015
Q2
$1.83M Buy
+11,898
New +$1.91M 0.05% 342
2015
Q1
Sell
-16,208
Closed -$2.55M 1080
2014
Q4
$2.58M Buy
+16,208
New +$2.53M 0.04% 355

Other funds holding AMGN

Integral Derivatives's AMGN Position: Q1 2018 in Review

Integral Derivatives opened a new position in Amgen (AMGN) in Q1 2018: 5,401 shares worth $921K. The stake represents 0.02% of the portfolio and ranks #257 among its holdings. This is a return to the name: Integral Derivatives previously reported a position in AMGN as recently as Q4 2016.

Integral Derivatives first reported a position in AMGN in Q4 2014 and has held it in 7 quarters since. The position peaked at $3.44M in Q3 2016. 1,750 funds tracked by Wall St. Rank hold AMGN as of Q1 2018.

  • Integral Derivatives held 5,401 shares of Amgen worth $921K as of Q1 2018.
  • Amgen was a new Integral Derivatives position in Q1 2018.
  • Amgen made up 0.02% of Integral Derivatives's portfolio in Q1 2018, its #257 holding.
  • Integral Derivatives first reported a position in Amgen in Q4 2014 and has held it in 7 quarters since.
  • Integral Derivatives's Amgen position peaked at $3.44M in Q3 2016.
  • 1,750 funds tracked by Wall St. Rank held Amgen as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.